Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease
Status:
Unknown status
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
Treatment for no-option heart patients with coronary artery disease. Procedure includes the
injection into the heart of a protein growth factor, administered by the Cordis Corp.
MyoStar injection catheter, to stimulate the growth of blood vessels around blocked coronary
arteries.